Readouts in rare blood cancers like myelofibrosis, WM and CLL are attracting keen interest at this year’s ASCO conference.

An Auckland man with aggressive blood cancer was weeks away from receiving cutting-edge CAR-T cell therapy through a New ...

Shares of Legend Biotech rose more than 40% Tuesday—on pace for the stock's biggest percentage increase on record—after the ...

May 27 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved AbbVie's drug to treat blastic plasmacytoid ...

Suleika Jaouad's cancer journey has influenced her advocacy and connection with fellow patients, emphasizing the importance of mental health and community support. Her experience highlights the ...

Called mezigdomide, the drug is one of two protein-degrading medicines Bristol Myers hopes to soon position as successors to ...

Every year, blood cancer survivors, supporters and advocates powerfully embody that metaphor during nearly 100 Light The Night events across the U.S. and Canada. Blood Cancer United’s signature ...

The Leukemia Research Foundation of Delaware (LRFDE), founded by Denni Ferrara, has committed $1 million to support pediatric ...